Clinical Trial Update: Ofatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ofatumumab plus chlorambucil versus chlorambucil alone in previously untreated chronic lymphocytic leukemia; trial terminated with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Chlorambucil (chlorambucil)
• Ofatumumab (ofatumumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Leukaemia, Lymphocytic, Chronic | Phase 3 | Status: TERMINATED | Results posted: 2014-03-26